Results 261 to 270 of about 38,837 (270)

Adverse Effects of Medication and Quality of Life in Patients Receiving Second Generation Antipsychotics: A Comparison of Long Acting Injectable and Oral Therapies

, 2016
Demet Sağlam Aykut, Filiz Civil Arslan, Ahmet Tiryaki, Evrim Özkorumak, Serdar Karakullukçu   +4 more
openalex   +1 more source

Physical Activity as a Tool to Improve Sleep Quality for Secure Psychiatric Inpatients: A Feasibility Study

Journal of Sleep Research, Volume 35, Issue 1, February 2026.
ABSTRACT People with a severe mental illness (SMI) often experience insomnia and disrupted sleep–wake cycles. Daytime physical activity (PA) can retrain the sleep/wake cycle, but PA engagement is often markedly low in SMI. It is hypothesised that frequent, intermittent, short bouts of daytime PA can improve sleep outcomes in SMI.
Poppy May Gardiner, Florence Emilie Kinnafick, Kieran C. Breen, Iuliana Hartescu   +3 more
wiley   +1 more source

Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Results on side effects

Mushde Shakir, Peter N. van Harten, Adriaan W. Hoogendoorn, Anne Willems, Diederik E. Tenback   +4 more
openalex   +2 more sources

Comparison of second generation antipsychotics: are there any differences in efficacy?

Annals of General Psychiatry, 2006
Papageorgiou George
doaj   +1 more source

Identification of key modules in metabolic syndrome induced by second-generation antipsychotics based on co-expression network analysis. [PDF]

Comput Struct Biotechnol J
Sun Y, Zhu C, Huang L, Luo C, Ju P, Chen J.   +5 more
europepmc   +1 more source

Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning. [PDF]

BMC Psychiatry
Ishigooka J, Nakagome K, Ohmori T, Iwata N, Inada K, Iga JI, Kishi T, Fujita K, Kikuchi Y, Shichijo T, Tabuse H, Koretsune S, Terada H, Terada H, Kishimoto T, Tsutsumi Y, Ohi K.   +16 more
europepmc   +1 more source

Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials. [PDF]

Schizophr Bull
Wang D, Schneider-Thoma J, Siafis S, Burschinski A, Dong S, Wu H, Zhu Y, Davis JM, Priller J, Leucht S.   +9 more
europepmc   +1 more source

Is antipsychotic medication stigmatizing for people with mental illness? [PDF]

, 2009
Jenkins, Janis H, Sajatovic, Martha
core